NASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis $0.17 0.00 (-2.22%) Closing price 04:00 PM EasternExtended Trading$0.18 +0.01 (+5.48%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About DocGo Stock (NASDAQ:DCGO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DocGo alerts:Sign Up Key Stats Today's Range$0.17▼$0.1950-Day Range$0.18▼$0.4052-Week Range$0.17▼$1.10Volume522,186 shsAverage Volume851,619 shsMarket Capitalization$16.99 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingHold Company Overview DocGo Inc. is a healthcare services company that delivers medical care and patient transportation outside traditional healthcare facilities. Its services include mobile healthcare programs, in-home and community-based care, and ambulance transportation. The company uses a technology platform to coordinate clinicians, emergency medical technicians and other healthcare professionals. Its mobile services support healthcare providers, government agencies and other organizations seeking to deliver care in homes and community settings. DocGo traces its origins to Ambulnz, a medical transportation and mobile health company founded in 2015. It began trading as a public company in 2021 following a business combination with Motion Acquisition Corp. The company serves clients in the United States and the United Kingdom.AI Generated. May Contain Errors. Read More DocGo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreDCGO MarketRank™: 2.52113444232 of 5 starsDocGo scored higher than 50% of companies evaluated by MarketBeat, and ranked 997th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingDocGo has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialDocGo has a consensus price target of $1.50, representing about 752.3% upside from its current price of $0.18.Amount of Analyst CoverageDocGo has only been the subject of 2 research reports in the past 90 days.Read more about DocGo's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DocGo are expected to grow in the coming year, from ($0.25) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDocGo has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.27% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 3.86, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in DocGo has recently increased by 7.87%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. News and Social Media1.1 / 5News SentimentN/A News SentimentDocGo has a news sentiment score of -0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for DocGo this week, compared to 2 articles on an average week. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have not sold or bought any company stock.Percentage Held by Insiders5.10% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DCGO Stock News HeadlinesDocGo Announces CEO Transition and Separation AgreementNovember 13, 2026 | tipranks.comDocGo (NASDAQ:DCGO) Stock Price Target Cut by Needham & Company LLCNovember 12, 2026 | americanbankingnews.comThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 19 at 1:00 AM | Digest Publishing (Ad)DocGo (DCGO) Q3 2026 Earnings Call TranscriptNovember 10, 2026 | finance.yahoo.comDocGo Inc. (DCGO) Q3 2026 Earnings Call TranscriptNovember 10, 2026 | seekingalpha.comDocGo Inc. (DCGO) Stock Falls on Q3 2026 EarningsNovember 9, 2026 | quiverquant.comQDocGo Announces Third Quarter 2026 Results and CEO TransitionNovember 9, 2026 | businesswire.comDocGo (DCGO) Expected to Release Quarterly Earnings on MondayNovember 8, 2026 | americanbankingnews.comSee More Headlines DCGO Stock Analysis - Frequently Asked Questions How have DCGO shares performed this year? DocGo's stock was trading at $0.8778 at the beginning of the year. Since then, DCGO stock has decreased by 79.9% and is now trading at $0.1760. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by $0.06. The firm earned $73.43 million during the quarter, compared to analysts' expectations of $76.96 million. DocGo had a negative trailing twelve-month return on equity of 63.66% and a negative net margin of 60.96%. Read the conference call transcript. Who are DocGo's major shareholders? DocGo's top institutional investors include State Street Corp (0.41%), Empowered Funds LLC (0.10%), Ieq Capital LLC (0.08%) and Goldman Sachs Group Inc. (0.07%). Insiders that own company stock include Lee Bienstock, Michael J Burdiek, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DocGo own? Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Alibaba Group (BABA), IonQ (IONQ), Occidental Petroleum (OXY), Pfizer (PFE) and AT&T (T). Company Calendar Last Earnings11/09/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (20m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 DCGO's financial health is in the Red zone, according to TradeSmith. DCGO has been in this zone for over 20 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:DCGO CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees3,568Year FoundedN/APrice Target and Rating Average Price Target for DocGo$1.50 High Price Target$2.50 Low Price Target$1.00 Potential Upside/Downside+774.1%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($1.85) Trailing P/E RatioN/A Forward P/E Ratio17.16 P/E GrowthN/ANet Income-$182.40 million Net Margins-60.96% Pretax Margin-55.30% Return on Equity-63.66% Return on Assets-33.31% Debt Debt-to-Equity RatioN/A Current Ratio1.38 Quick Ratio1.38 Sales & Book Value Annual Sales$297.34 million Price / Sales0.06 Cash Flow$0.05 per share Price / Cash Flow3.31 Book Value$0.80 per share Price / Book0.21Miscellaneous Outstanding Shares98,992,000Free Float93,943,000Market Cap$16.99 million OptionableOptionable Beta1.03 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:DCGO) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.